AAAAAA

   
Results: 1-22 |
Results: 22
Advanced hypopharyngeal carcinoma treatment results according to treatmentmodalities
Authors: Kim, S Wu, HG Heo, DS Kim, KH Sung, MW Park, CI
Citation: S. Kim et al., Advanced hypopharyngeal carcinoma treatment results according to treatmentmodalities, HEAD NECK, 23(9), 2001, pp. 713-717
Development of terminal cancer prognostic score as an index in terminally ill cancer patients
Authors: Yun, YH Heo, DS Heo, BY Yoo, TW Bae, JM Ahn, SH
Citation: Yh. Yun et al., Development of terminal cancer prognostic score as an index in terminally ill cancer patients, ONCOL REP, 8(4), 2001, pp. 795-800
Protest of Korean medical doctors against the government policy in 2000
Authors: Heo, DS
Citation: Ds. Heo, Protest of Korean medical doctors against the government policy in 2000, J KOR MED S, 16(1), 2001, pp. 1-1
Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer
Authors: Kim, HK Park, IA Heo, DS Noh, DY Choe, KJ Bang, YJ Kim, NK
Citation: Hk. Kim et al., Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer, EUR J SUR O, 27(5), 2001, pp. 464-471
Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions
Authors: Cho, KH Kim, CW Heo, DS Lee, DS Choi, WW Rim, JH Han, WS
Citation: Kh. Cho et al., Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions, CLIN EXP D, 26(3), 2001, pp. 242-247
Prognostic factors of Krukenberg's tumor
Authors: Kim, HK Heo, DS Bang, YJ Kim, NK
Citation: Hk. Kim et al., Prognostic factors of Krukenberg's tumor, GYNECOL ONC, 82(1), 2001, pp. 105-109
A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies
Authors: Kim, NK Kim, TY Shin, SG Park, YI Lee, JA Cho, YB Kim, KH Kim, DK Heo, DS Bang, YJ
Citation: Nk. Kim et al., A phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies, CANCER, 91(8), 2001, pp. 1549-1556
The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines
Authors: Kang, JO Yoon, SJ Kim, NK Heo, DS
Citation: Jo. Kang et al., The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines, INT J ONCOL, 16(6), 2000, pp. 1159-1163
Enhancement of adenoviral transduction with polycationic liposomes in vivo
Authors: Lee, SG Yoon, SJ Kim, CD Kim, K Lim, DS Yeom, YI Sung, MW Heo, DS Kim, NK
Citation: Sg. Lee et al., Enhancement of adenoviral transduction with polycationic liposomes in vivo, CANC GENE T, 7(10), 2000, pp. 1329-1335
Effect of GM-CSF and IL-2 Co-expression on the anti-tumor immune response
Authors: Lee, SG Heo, DS Yoon, SJ Jee, YS Kang, JO Kim, KJ Kim, CD Sung, MW Kim, NK
Citation: Sg. Lee et al., Effect of GM-CSF and IL-2 Co-expression on the anti-tumor immune response, ANTICANC R, 20(4), 2000, pp. 2681-2686
Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model
Authors: Sung, MW Lee, SG Yoon, SJ Lee, HJ Heo, DS Kim, KH Koh, TY Choi, SH Park, SW Koo, JW Kwon, TY
Citation: Mw. Sung et al., Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model, ANTICANC R, 20(3A), 2000, pp. 1653-1656
Reduced expression of MHC class I antigen in human cancer cell lines with defective LMP-7
Authors: Yoon, SJ Kang, JO Park, JS Kim, NK Heo, DS
Citation: Sj. Yoon et al., Reduced expression of MHC class I antigen in human cancer cell lines with defective LMP-7, ANTICANC R, 20(2A), 2000, pp. 949-953
Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines
Authors: Lee, SE Jin, RJ Lee, SG Yoon, SJ Park, MS Heo, DS Choi, H
Citation: Se. Lee et al., Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines, ANTICANC R, 20(1A), 2000, pp. 417-422
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillarylymph node positive breast carcinoma - Results of a randomized controlled trial
Authors: Bang, SM Heo, DS Lee, KH Byun, JH Chang, HM Noh, DY Choe, KJ Bang, YJ Kim, SR Kim, NK
Citation: Sm. Bang et al., Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillarylymph node positive breast carcinoma - Results of a randomized controlled trial, CANCER, 89(12), 2000, pp. 2521-2526
Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia
Authors: Cho, EK Heo, DS Seol, JG Seo, EJ Chi, HS Kim, ES Lee, YY Kim, BK Kim, NK
Citation: Ek. Cho et al., Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia, BR J HAEM, 111(1), 2000, pp. 216-222
Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma
Authors: Huh, J Cho, K Heo, DS Kim, JF Kim, CW
Citation: J. Huh et al., Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma, AM J HEMAT, 60(3), 1999, pp. 205-214
Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma
Authors: Hong, SM Wu, HG Chie, EK Bang, YJ Heo, DS Kim, KH Sung, MW Park, CI
Citation: Sm. Hong et al., Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma, INT J RAD O, 45(4), 1999, pp. 901-905
A spindle cell tumor of unknown origin and diffuse bone marrow involvementin a patient with hypercalcemia
Authors: Yim, JJ Kang, GH Heo, DS Kim, NK
Citation: Jj. Yim et al., A spindle cell tumor of unknown origin and diffuse bone marrow involvementin a patient with hypercalcemia, TUMORI, 85(6), 1999, pp. 526-529
Combination gene therapy of IL-12 and allogeneic MHC class I gene via stimulating NK cytolytic activity
Authors: Yoon, SJ Heo, DS Kang, JO Kim, NK
Citation: Sj. Yoon et al., Combination gene therapy of IL-12 and allogeneic MHC class I gene via stimulating NK cytolytic activity, ANTICANC R, 19(5B), 1999, pp. 4337-4342
The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck
Authors: Kim, CD Sung, MW Lee, SJ Heo, DS Yoon, SJ Kim, KH
Citation: Cd. Kim et al., The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck, ANTICANC R, 19(1A), 1999, pp. 455-459
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
Authors: Kim, NK Im, SA Kim, DW Lee, MH Jung, CW Cho, EK Lee, JT Ahn, JS Heo, DS Bang, YJ
Citation: Nk. Kim et al., Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma, CANCER, 86(7), 1999, pp. 1109-1115
Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma
Authors: Kim, NK Kim, HK Park, BJ Kim, MS Kim, YI Heo, DS Bang, YJ
Citation: Nk. Kim et al., Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma, CANCER, 85(7), 1999, pp. 1490-1499
Risultati: 1-22 |